Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.07 USD | +3.06% | +3.00% | -12.39% |
May. 09 | Transcript : LifeStance Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | LifeStance Health Q1 Loss Narrows as Revenue Increases; 2024 Revenue Outlook Reiterated | MT |
Evolution of the average Target Price on LifeStance Health Group, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering LifeStance Health Group, Inc.
Jefferies & Co. | |
Goldman Sachs | |
UBS | |
Barclays | |
JPMorgan Chase | |
Morgan Stanley | |
Cowen | |
William Blair & Co. |
EPS Revisions
- Stock Market
- Equities
- LFST Stock
- Consensus LifeStance Health Group, Inc.